Core Viewpoint - Bohai Leasing's stock price has shown fluctuations, with a recent increase of 2.25% and a total market capitalization of 22.45 billion yuan, despite a year-to-date decline of 3.71% [1] Financial Performance - For the first half of 2025, Bohai Leasing reported operating revenue of 28.46 billion yuan, representing a year-on-year growth of 75.91%, while the net profit attributable to shareholders was -2.02 billion yuan, a significant decrease of 381.80% compared to the previous period [2] Shareholder Information - As of June 30, 2025, the number of shareholders for Bohai Leasing was 121,900, a decrease of 8.99% from the previous period, with an average of 44,243 circulating shares per shareholder, an increase of 9.88% [2] - The company has cumulatively distributed 1.136 billion yuan in dividends since its A-share listing, with no dividends paid in the last three years [3] Stock Trading Activity - On October 21, Bohai Leasing's stock traded at 3.63 yuan per share, with a trading volume of 1.11 billion yuan and a turnover rate of 0.58% [1] - The stock has experienced a 5.83% increase over the last five trading days, while it has decreased by 0.27% over the last 20 days and 0.55% over the last 60 days [1] Business Overview - Bohai Leasing, established on August 30, 1993, and listed on July 16, 1996, primarily engages in financing leasing and operating leasing for aircraft and containers [1] - The revenue composition includes 53.84% from aircraft sales, 42.92% from operating leasing, 1.58% from financing leasing and consulting, 1.45% from container sales, and 0.19% from other sources [1]

Core Viewpoint - Shentong Express has experienced a decline in stock price recently, despite a significant increase in its stock price year-to-date, indicating potential volatility in the market [1][2]. Group 1: Stock Performance - As of October 21, Shentong Express's stock price was 15.62 CNY per share, down 2.19% during the trading session [1]. - The stock has increased by 55.21% year-to-date, but has seen a decline of 11.60% in the last five trading days and 14.41% in the last twenty days [1]. - The company has appeared on the "龙虎榜" (a trading board for stocks with significant trading volume) once this year, with a net buy of 14.11 million CNY on July 25 [1]. Group 2: Financial Performance - For the first half of 2025, Shentong Express reported revenue of 25.025 billion CNY, a year-on-year increase of 16.02%, and a net profit attributable to shareholders of 453 million CNY, up 3.73% year-on-year [2]. - The company has distributed a total of 1.614 billion CNY in dividends since its A-share listing, with 131 million CNY distributed in the last three years [3]. Group 3: Shareholder Information - As of June 30, 2025, the number of shareholders for Shentong Express was 42,500, an increase of 11.27% from the previous period [2]. - The average number of circulating shares per shareholder was 35,095, a decrease of 10.13% from the previous period [2]. - The fifth-largest circulating shareholder, Hong Kong Central Clearing Limited, reduced its holdings by 19.72 million shares to 43.2118 million shares [3].

10月21日，中华企业盘中上涨2.03%，截至10:01，报3.01元/股，成交5244.98万元，换手率0.29%，总市 值181.99亿元。 资金流向方面，主力资金净流入557.01万元，特大单买入385.54万元，占比7.35%，卖出0.00元，占比 0.00%；大单买入1339.89万元，占比25.55%，卖出1168.41万元，占比22.28%。 责任编辑：小浪快报 中华企业所属申万行业为：房地产-房地产开发-住宅开发。所属概念板块包括：低价、土地流转、国资 改革、中盘、融资融券等。 截至6月30日，中华企业股东户数5.69万，较上期减少4.59%；人均流通股106333股，较上期增加 4.81%。2025年1月-6月，中华企业实现营业收入66.79亿元，同比增长526.09%；归母净利润5.21亿元， 同比增长248.09%。 分红方面，中华企业A股上市后累计派现43.41亿元。近三年，累计派现1.81亿元。 机构持仓方面，截止2025年6月30日，中华企业十大流通股东中，香港中央结算有限公司位居第七大流 通股东，持股3128.88万股，相比上期增加831.50万股。南方中证房地产ETF发起联接A ...

Core Viewpoint - Nuo Cheng Jian Hua's stock price has seen a significant increase of 93.24% year-to-date, but has recently experienced a decline of 2.94% over the past five trading days and 20.66% over the past 60 days [2][3] Company Overview - Nuo Cheng Jian Hua, established on November 3, 2015, and listed on September 21, 2022, is based in Beijing and focuses on the research, production, and commercialization of biopharmaceuticals, particularly in oncology and autoimmune diseases [2] - The company's revenue composition includes 87.67% from drug sales, 12.04% from technology licensing, and 0.15% each from testing and research services [2] Financial Performance - For the first half of 2025, Nuo Cheng Jian Hua reported a revenue of 731 million yuan, representing a year-on-year growth of 74.26%, while the net profit attributable to shareholders was -30.09 million yuan, an increase of 88.51% year-on-year [3] Shareholder Information - As of June 30, 2025, the number of shareholders increased by 13.80% to 15,200, with an average of 0 circulating shares per person [3] - Notable institutional shareholders include China Europe Medical Health Mixed A and others, with changes in their holdings reflecting market dynamics [3]

Core Viewpoint - Dalian Wanda's stock price has shown fluctuations, with a recent increase of 2.18%, and the company has experienced a year-to-date stock price increase of 7.89% [1] Group 1: Stock Performance - As of October 21, Dalian Wanda's stock price reached 3.28 CNY per share, with a trading volume of 13.67 million CNY and a market capitalization of 14.06 billion CNY [1] - The stock has increased by 2.50% over the last five trading days, decreased by 3.53% over the last 20 days, and increased by 8.97% over the last 60 days [1] Group 2: Financial Performance - For the first half of 2025, Dalian Wanda reported a revenue of 15.23 billion CNY, a year-on-year decrease of 5.29%, while the net profit attributable to shareholders was 109 million CNY, reflecting a year-on-year increase of 129.87% [2] Group 3: Shareholder Information - As of June 30, 2025, the number of Dalian Wanda shareholders was 96,600, a decrease of 2.60% from the previous period, with an average of 41,454 circulating shares per shareholder, an increase of 2.67% [2] - The company has cumulatively distributed 2.05 billion CNY in dividends since its A-share listing, with no dividends distributed in the last three years [3] - The fourth largest circulating shareholder is Hong Kong Central Clearing Limited, holding 24.60 million shares, a decrease of 2.93 million shares from the previous period [3]

Core Insights - The stock price of Feima International increased by 2.16% on October 21, reaching 4.25 CNY per share, with a total market capitalization of 11.31 billion CNY [1] Financial Performance - Year-to-date, Feima International's stock price has risen by 59.77%, with recent performance showing an 8.97% increase over the last five trading days, a 20.74% increase over the last 20 days, and a 47.06% increase over the last 60 days [1] - For the first half of 2025, Feima International reported revenue of 1.09 million CNY, a year-on-year decrease of 6.46%, and a net profit attributable to shareholders of 261.15 thousand CNY, down 92.18% year-on-year [2] Shareholder Information - As of June 30, Feima International had 84,800 shareholders, an increase of 29.58% from the previous period, with an average of 31,328 circulating shares per shareholder, a decrease of 22.83% [2] Business Overview - Feima International, established on July 9, 1998, and listed on January 30, 2008, is primarily engaged in supply chain management services and environmental new energy business, with revenue composition as follows: 81.71% from the environmental new energy sector, 11.34% from comprehensive logistics services, 6.47% from PPP project construction services, and 0.47% from trade execution services [1] Dividend Information - Since its A-share listing, Feima International has distributed a total of 390 million CNY in dividends, with no dividends paid in the last three years [3]

Core Viewpoint - 弘业期货 has shown a positive performance with a 1.68% increase in stock price, reaching a market capitalization of 10.955 billion yuan, indicating potential growth in the futures market [1]. Company Overview - 弘业期货股份有限公司 primarily engages in commodity futures brokerage, financial futures brokerage, futures investment consulting, asset management, fund sales, and financial asset investment [2][7]. - The company is the first A+H share listed company in the futures industry and is controlled by the Jiangsu Provincial Government State-owned Assets Supervision and Administration Commission [3][7]. - As of June 30, 2025, 弘业期货 reported a revenue of 0.00 yuan and a net profit of -3.6056 million yuan, reflecting a year-on-year decrease of 128.17% [7]. Financial Performance - The company has a total market capitalization of 10.955 billion yuan and a trading volume of 102 million yuan with a turnover rate of 1.24% [1]. - The average trading cost of the stock is 12.19 yuan, with the stock price approaching a resistance level of 10.97 yuan, suggesting a potential for upward movement if the resistance is broken [6]. - The company has distributed a total of 44.3422 million yuan in dividends since its A-share listing [8]. Shareholder Structure - As of June 30, 2025, the number of shareholders increased by 43.72% to 62,600, with the average circulating shares per person remaining at 0 [7]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited and Southern CSI 1000 ETF, indicating a diversified shareholder base [8].

Core Viewpoint - COFCO Sugar's stock price has experienced significant fluctuations, with a year-to-date increase of 49.08% but a recent decline of 9.70% over the past five trading days [1] Financial Performance - For the first half of 2025, COFCO Sugar reported revenue of 11.767 billion yuan, a year-on-year decrease of 21.32%, and a net profit attributable to shareholders of 445 million yuan, down 48.42% year-on-year [2] - Cumulative cash dividends since the A-share listing amount to 5.4 billion yuan, with 3.722 billion yuan distributed over the past three years [3] Shareholder Structure - As of June 30, 2025, the number of COFCO Sugar shareholders increased to 107,600, with an average of 19,874 circulating shares per person, a decrease of 0.72% [2] - The top circulating shareholders include Hongli Low Volatility (512890) as the second-largest, holding 38.7445 million shares, an increase of 6.5709 million shares from the previous period [3]

Core Viewpoint - The stock price of Miaokelan has shown a significant increase of 45.64% year-to-date, despite a recent decline of 2.03% in intraday trading on October 20, 2023, indicating volatility in the market [2]. Group 1: Stock Performance - As of October 20, 2023, Miaokelan's stock price is reported at 26.07 CNY per share, with a trading volume of 1.89 billion CNY and a turnover rate of 1.40%, resulting in a total market capitalization of 132.97 billion CNY [1]. - The stock has experienced a 4.66% increase over the last five trading days and a 3.53% increase over the last 20 days, while it has seen a decline of 9.60% over the last 60 days [2]. Group 2: Company Overview - Miaokelan, established on November 29, 1988, and listed on December 6, 1995, is located in the Jintai Building, 1398 Jinqiao Road, Pudong New District, Shanghai [2]. - The company specializes in the research, production, and sales of dairy products, primarily focusing on cheese, which constitutes 83.20% of its main business revenue. Other revenue sources include trade (8.94%), liquid milk (7.29%), and others (0.57%) [2]. Group 3: Financial Performance - For the first half of 2025, Miaokelan reported a revenue of 2.567 billion CNY, reflecting a year-on-year growth of 33.52%. The net profit attributable to the parent company was 133 million CNY, marking a significant increase of 73.19% year-on-year [2]. - The company has distributed a total of 368 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3]. Group 4: Shareholder Information - As of June 30, 2025, the number of shareholders for Miaokelan is reported at 34,300, a decrease of 23.14% from the previous period, while the average circulating shares per person increased by 30.11% to 14,909 shares [2]. - Notably, Hong Kong Central Clearing Limited has exited the list of the top ten circulating shareholders [3].

Core Viewpoint - Noposion's stock price has shown fluctuations, with a recent increase of 2.00% to 11.21 CNY per share, while experiencing a net outflow of funds from major investors [1] Group 1: Company Overview - Noposion was established on September 18, 1999, and listed on February 18, 2008, focusing on agricultural protection products and integrated services [2] - The company's main products include pesticide formulations, plant nutrition, and pesticide solubilizers, with revenue composition as follows: fresh consumption 49.14%, insecticides 18.67%, fungicides 15.42%, plant nutrition 8.26%, herbicides 5.80%, plant growth regulators and additives 1.20%, crop series 0.26%, and agricultural services and trade 0.15% [2] - Noposion belongs to the agricultural industry, specifically in the sub-sector of other planting industries, and is associated with concepts such as mid-cap, margin trading, smart agriculture, and industrial hemp [2] Group 2: Financial Performance - For the first half of 2025, Noposion achieved operating revenue of 3.679 billion CNY, representing a year-on-year growth of 8.20%, and a net profit attributable to shareholders of 648 million CNY, up 17.35% year-on-year [2] - The company has distributed a total of 1.767 billion CNY in dividends since its A-share listing, with 653 million CNY distributed in the last three years [3] Group 3: Shareholder Information - As of June 30, 2025, Noposion had 43,800 shareholders, an increase of 21.47% from the previous period, with an average of 17,944 circulating shares per person, a decrease of 17.01% [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the third-largest with 23.2563 million shares, while Southern CSI 1000 ETF is the ninth-largest with 6.4971 million shares, both being new shareholders [3]